Topics

• ANTITRUST

• Asset Management

• Data, Privacy & Cybersecurity

• Digital Health

• Employee Benefits/ERISA

• Enforcement

• False Claims Act

• FDA REGULATORY

• Health Care

• Intellectual Property

• PRIVATE EQUITY

• TAX

Capital Insights

Analysis

• Podcast: Private Fund Regulatory Update: Recent Developments Regarding Management Fee Calculation and Electronic Communications
  (January 24, 2022)
• How Would an ESG-Friendly DOL Final Rule Change the Investment Marketplace for ERISA Plans?
  (January 18, 2022)
• Talkin' Trade: What Remedies Can The International Trade Commission Impose?
  (January 5, 2022)
• President Biden Signs Uyghur Forced Labor Prevention Act – Overview and Near-term Compliance Recommendations
  (January 4, 2022)
• A New Year for Drug Pricing and Price Reporting? What’s Happening Now and What’s New for 2022
  (December 14, 2021)

In The News

• In Law360, Life Sciences Attorneys Examine FDA’s Transition Plans for Medical Devices Under Emergency Use Authorizations and Enforcement Policies
  (January 20, 2022)
• In National Law Journal, Matt Rizzolo Discusses Lateral Moves in the ITC Bar
  (January 20, 2022)
• On HIMSS-TV, Christine Moundas Analyzes Digital Health 2021 Highlights and 2022 Outlook
  (January 5, 2022)
• In Law360, Attorneys Analyze DOJ Civil Cyber-Fraud Initiative Impact on Health Care Companies
  (December 22, 2021)
• In Law360, Ed McNicholas Examines Top Data Privacy Developments of 2021
  (December 22, 2021)